Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net loss $ (94,734) $ (1,681)
Adjustments to reconcile net loss to net cash used in operating activities    
Loss on remeasurement of private warrants 80,697 0
Share-based compensation 6,665 147
Depreciation and amortization 2,100 870
Loss on writeoff of deferred loan costs 1,900 0
Amortization of debt issuance costs and debt discounts 82 233
Amortization of right-of-use assets and lease liability 41 128
Other 38 90
Changes in operating assets and liabilities - net of acquisitions:    
Accounts receivable, net (3,509) (1,736)
Inventories (3,204) (3,133)
Prepaid expenses and other current assets (1,498) (42)
Other assets 125 (191)
Accounts payable (669) 268
Accrued and other long-term liabilities (2,123) (156)
Unearned revenue and contract liabilities (119) (412)
Net cash used in operating activities (14,208) (5,615)
Cash flows from investing activities    
Purchases of property, plant and equipment (23,893) (15,340)
Net cash used in investing activities (23,893) (15,340)
Cash flows from financing activities    
Principal payments on long-term debt (27,037) (404)
Proceeds from exercise of stock options 1,191 0
Proceeds from long-term debt 120 2,435
Payments for debt issuance costs (25) (27)
Proceeds from NMTC financing 0 91
Proceeds from issuance of common stock, net of issuance costs (815) 24,916
Net cash (used in) provided by financing activities (26,566) 27,011
Net (decrease) increase in cash and cash equivalents and restricted cash (64,667) 6,056
Cash and cash equivalents and restricted cash    
Cash and cash equivalents and restricted cash-beginning of period 379,897 6,261
Cash and cash equivalents and restricted cash-end of period $ 315,230 $ 12,317